» Articles » PMID: 24502460

Predictors of Medication Adherence Among HIV-positive Women in North America

Overview
Publisher Elsevier
Date 2014 Feb 8
PMID 24502460
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the relationships among contextual, environmental, and regulatory factors with antiretroviral (ARV) medication adherence to assist care providers in improving care for women living with HIV.

Design: Descriptive, multicenter study.

Setting: Sixteen HIV clinics and service organizations in North America.

Participants: This convenience sample was drawn from a larger study of 2,182 persons living with HIV recruited from clinics and service from September 2009 to January 2011. We included 383 women living with HIV who were taking ARV medications.

Methods: We assessed the relationship of contextual, environmental, and psychological factors specific to women living with HIV in relation to adherence to ARV medication. Descriptive and multivariate statistics were used to examine the effects of these factors on self-reported ARV drug adherence.

Results: Age, depression symptoms, stigma, engagement with health care provider, and four psychological factors were correlated with self-reported ARV medication adherence (p = .01). Regression analysis indicated that adherence self-efficacy and depression symptoms accounted for 19% for 3-day and 22% for 30-day self-reported medication adherence.

Conclusions: Adherence self-efficacy and depression symptoms predict ARV medication adherence in women and should be evaluated by nurses. Future research is needed to identify antecedents to and interventions that support adherence self-efficacy and decrease depression symptoms.

Citing Articles

to Address Substance Use, Violence, and Depression in Women Living with HIV.

Simon L, Livingston A, Tiamiyu K, Beals D, Muehlenhaupt A, Deerr R J CME. 2024; 13(1):2396256.

PMID: 39253278 PMC: 11382687. DOI: 10.1080/28338073.2024.2396256.


A Systematic Review of the Impact of HIV-Related Stigma and Serostatus Disclosure on Retention in Care and Antiretroviral Therapy Adherence Among Women with HIV in the United States/Canada.

Nawfal E, Gray A, Sheehan D, Ibanez G, Trepka M AIDS Patient Care STDS. 2023; 38(1):23-49.

PMID: 38150524 PMC: 10794841. DOI: 10.1089/apc.2023.0178.


Structural equation modeling to estimate treatment adherence based on the light triad of personality and sense of coherence in patients with type-2 diabetes: examining the mediating role of psychological well-being.

Mousavi S, Bagheri S, Heris N, Matbouraftar P, Azarian M, Kordbagheri M Front Psychol. 2023; 14:1285808.

PMID: 38090178 PMC: 10711286. DOI: 10.3389/fpsyg.2023.1285808.


Patient-Provider Relationships and Antiretroviral Therapy Adherence and Durable Viral Suppression Among Women with HIV, Miami-Dade County, Florida, 2021-2022.

Trepka M, Ward M, Fennie K, Sheehan D, Fernandez S, Li T AIDS Patient Care STDS. 2023; 37(7):361-372.

PMID: 37432309 PMC: 10354312. DOI: 10.1089/apc.2023.0029.


Stress, coping and the acceptability of mindfulness skills among pregnant and parenting women living with HIV in the United States: A focus group study.

Waldron E, Miller E, Wee V, Statton A, Moskowitz J, Burnett-Zeigler I Health Soc Care Community. 2022; 30(6):e6255-e6266.

PMID: 36214377 PMC: 10092748. DOI: 10.1111/hsc.14063.


References
1.
Weiss S, Tobin J, Antoni M, Ironson G, Ishii M, Vaughn A . Enhancing the health of women living with HIV: the SMART/EST Women's Project. Int J Womens Health. 2011; 3:63-77. PMC: 3061850. DOI: 10.2147/IJWH.S5947. View

2.
Voils C, Barroso J, Hasselblad V, Sandelowski M . In or out? Methodological considerations for including and excluding findings from a meta-analysis of predictors of antiretroviral adherence in HIV-positive women. J Adv Nurs. 2007; 59(2):163-77. PMC: 2329804. DOI: 10.1111/j.1365-2648.2007.04289.x. View

3.
Martinez J, Harper G, Carleton R, Hosek S, Bojan K, Clum G . The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care. AIDS Patient Care STDS. 2011; 26(2):108-15. PMC: 3266519. DOI: 10.1089/apc.2011.0178. View

4.
Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T . Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000; 19(2):124-33. View

5.
Walsh J, Mandalia S, Gazzard B . Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002; 16(2):269-77. DOI: 10.1097/00002030-200201250-00017. View